JUL 19, 2019 7:00 AM PDT

New hope for metastatic cancer treatment

New research recently published in the journal iScience takes a deeper look into metastatic cancers, finding that a particular gene called mEAK-7 may play a role. Metastasis refers to the process by which cancers spread and while it is often extremely dangerous, scientists and doctors are still trying to understand just why and how it happens. The study was led by Dr. Paul Krebsbach, dean of UCLA's School of Dentistry and professor of periodontics.

Dr. Krebsbach’s team looked at the role of mEAK-7 in non-small cell lung cancer, gathering tumor cell genetic information from various databases in addition to using tissue samples from cancer patients. Previous studies had found that mEAK-7 expression affects cell proliferation and migration, so perhaps it is unsurprising that the researchers found the high expression of mEAK-7 in metastatic non-small cell lung cancer.

Confirming this, adds Dr. Joe Nguyen, first author and postdoctoral scholar at the National Cancer Institute, "We also discovered that mEAK-7 was expressed in primary cancer cells but not expressed in non-cancerous cells, which shows that the protein could be a key culprit in cancer metastasis."

However more exciting than this discovery, perhaps, was what the researchers found in regards to a new alternative mTOR signaling pathway. (mTOR is a gene that regulates normal cell growth, proliferation and survival and two mTOR signaling pathways have already been discovered.)

"This third complex or pathway is very important for cancer stem cells, which begin the process of colony formation and cell proliferation, and lead to metastasis that is the leading cause of death in most cancers," Krebsbach said. "We determined that there are high mEAK-7 protein levels in the tumors and lymph nodes of metastatic cancer patients. [Therefore, the] development of mEAK-7 inhibitors may benefit patients with metastatic cancers that demonstrate aberrant mTOR signaling associated with high levels of mEAK-7."

Metastatic cancers are the leading cause of most cancer deaths. Photo: Pixabay

The researchers say that this discovery is significant to the development of future treatments for patients with metastatic cancers. "Understanding the molecular interactions of metastatic cancer is crucial to determining treatments for cancer at these later stages," said co-author Jin Koo Kim. "Currently, treatments for solid tumors include surgery and radiation therapies. However, many patients relapse, as the target tumors develop resistance to radiation and other treatments. This study found that this resistance is correlated to higher mEAK-7 expression in cancer cells."

Sources: Science Daily, iScience

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 25, 2020
Genetics & Genomics
JAN 25, 2020
Membrane-less Organelle Found to Play a Role in Preventing Cancer
In recent years, scientists have found that a phenomenon called phase separation plays a critical role in the functions of cells....
JAN 25, 2020
Genetics & Genomics
JAN 25, 2020
A Way to Predict Which Microbes Can Cause Cancer
Researchers have created a technique that can identify bacteria and viruses that are linked to cancer....
JAN 25, 2020
Genetics & Genomics
JAN 25, 2020
Making T-Cell Therapy Even More Effective
Curated w/video - CRISPR/Cas9 deletion of an enzyme resulted in longer lasting, more robust therapy....
JAN 25, 2020
Cell & Molecular Biology
JAN 25, 2020
When Migrating, Cancer Cells Choose the Path of Least Resistance
Cancer becomes most deadly when it has metastasized - when cancerous cells move away from the site where cancer started growing....
JAN 25, 2020
Drug Discovery & Development
JAN 25, 2020
Can Cancer Drugs Treat Lung Damage?
Can therapeutics used in the treatment of cancer be a breakthrough for pulmonary disease? Specifically, chronic obstructive pulmonary disease (COPD)? &ldqu...
JAN 25, 2020
Cancer
JAN 25, 2020
What's the deal with turmeric?
Have you fallen for the turmeric craze? That little orange root that yellows your fingers when you peel it has become very popular recently for its medicin...
Loading Comments...